Dr Peter Adams, MD | |
3220 Dixie Hwy, Erlanger, KY 41018-1884 | |
(606) 393-6695 | |
Not Available |
Full Name | Dr Peter Adams |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 3220 Dixie Hwy, Erlanger, Kentucky |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831177120 | NPI | - | NPPES |
64057516 | Medicaid | KY |
Entity Name | Recover Together Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346736758 PECOS PAC ID: 7810247533 Enrollment ID: O20201023002201 |
News Archive
A two-day WHO and World Bank ministerial-level meeting on universal health coverage (UHC) began in Geneva on Monday, bringing "together ministers of finance and health from 27 countries with other high-level stakeholders" to discuss "exploring ways that countries are progressing towards universal health coverage, sharing innovative solutions and identifying actions the global community can take to support efforts," the Global Dispatch reports.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office has issued U.S. patent no. 7,915,307, entitled "Methods of Improving the Pharmacokinetics of Doxepin."
A supplemental spending bill that is expected to include earthquake relief aid for Haiti will be considered by the full House Defense Appropriations Subcommittee during the week of April 26 and will not be written this week as several aides and members had anticipated, C.W. Bill Young, the committee's ranking Republican from Florida, said, CQ Today reports.
Abnormally high or low blood calcium levels are linked to an increased chance of premature death in non-dialysis kidney disease patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Peter Adams, MD 3220 Dixie Hwy, Erlanger, KY 41018-1884 Ph: (606) 393-6695 | Dr Peter Adams, MD 3220 Dixie Hwy, Erlanger, KY 41018-1884 Ph: (606) 393-6695 |
News Archive
A two-day WHO and World Bank ministerial-level meeting on universal health coverage (UHC) began in Geneva on Monday, bringing "together ministers of finance and health from 27 countries with other high-level stakeholders" to discuss "exploring ways that countries are progressing towards universal health coverage, sharing innovative solutions and identifying actions the global community can take to support efforts," the Global Dispatch reports.
Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office has issued U.S. patent no. 7,915,307, entitled "Methods of Improving the Pharmacokinetics of Doxepin."
A supplemental spending bill that is expected to include earthquake relief aid for Haiti will be considered by the full House Defense Appropriations Subcommittee during the week of April 26 and will not be written this week as several aides and members had anticipated, C.W. Bill Young, the committee's ranking Republican from Florida, said, CQ Today reports.
Abnormally high or low blood calcium levels are linked to an increased chance of premature death in non-dialysis kidney disease patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN).
WHO today issued a public statement calling for the disclosure of results from clinical trials for medical products, whatever the result.The move aims to ensure that decisions related to the safety and efficacy of vaccines, drugs and medical devices for use by populations are supported by the best available evidence.
› Verified 7 days ago